Marksans Pharma consolidated net profit rises 8.26% in the December 2025 quarter
Sales rise 10.64% to Rs 754.43 crore
Net profit of Marksans Pharma rose 8.26% to Rs 113.20 crore in the quarter ended December 2025 as against Rs 104.56 crore during the previous quarter ended December 2024. Sales rose 10.64% to Rs 754.43 crore in the quarter ended December 2025 as against Rs 681.85 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var.Sales754.43681.85 11 OPM %21.3120.35 -PBDT174.95163.95 7 PBT150.62143.26 5 NP113.20104.56 8Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 05 2026 | 5:07 PM IST